Geynisman DM, Abbosh PH, Ross E, Zibelman MR, et al. Phase II Trial of Risk-Enabled Therapy After Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer (RETAIN 1). J Clin Oncol 2024 Dec 16:JCO2401214. doi: 10.1200/JCO-24-01214.
PMID: 39680823